Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP428512.RALAU_8UIjKDjuDq7FB7wywmgBOW_4gbidKiJMQWq77lk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP428512.RALAU_8UIjKDjuDq7FB7wywmgBOW_4gbidKiJMQWq77lk130_assertion type Assertion NP428512.RALAU_8UIjKDjuDq7FB7wywmgBOW_4gbidKiJMQWq77lk130_head.
- NP428512.RALAU_8UIjKDjuDq7FB7wywmgBOW_4gbidKiJMQWq77lk130_assertion description "[Vesicular monoamine transporter subtype 2 (VMAT2) activity protects against neurotoxins, and reduced VMAT2 expression is implicated in drug addiction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428512.RALAU_8UIjKDjuDq7FB7wywmgBOW_4gbidKiJMQWq77lk130_provenance.
- NP428512.RALAU_8UIjKDjuDq7FB7wywmgBOW_4gbidKiJMQWq77lk130_assertion evidence source_evidence_literature NP428512.RALAU_8UIjKDjuDq7FB7wywmgBOW_4gbidKiJMQWq77lk130_provenance.
- NP428512.RALAU_8UIjKDjuDq7FB7wywmgBOW_4gbidKiJMQWq77lk130_assertion SIO_000772 14730204 NP428512.RALAU_8UIjKDjuDq7FB7wywmgBOW_4gbidKiJMQWq77lk130_provenance.
- NP428512.RALAU_8UIjKDjuDq7FB7wywmgBOW_4gbidKiJMQWq77lk130_assertion wasDerivedFrom befree-2016 NP428512.RALAU_8UIjKDjuDq7FB7wywmgBOW_4gbidKiJMQWq77lk130_provenance.
- NP428512.RALAU_8UIjKDjuDq7FB7wywmgBOW_4gbidKiJMQWq77lk130_assertion wasGeneratedBy ECO_0000203 NP428512.RALAU_8UIjKDjuDq7FB7wywmgBOW_4gbidKiJMQWq77lk130_provenance.